Disposable Paper Filter for Sterilization Containers Paper, Medical Accessory, 100 DISP, Paper...
FDA Device Recall #Z-0114-2016 — Class II — September 17, 2015
Recall Summary
| Recall Number | Z-0114-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 17, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Stryker Craniomaxillofacial Division |
| Location | Portage, MI |
| Product Type | Devices |
| Quantity | 915 packs |
Product Description
Disposable Paper Filter for Sterilization Containers Paper, Medical Accessory, 100 DISP, Paper F, Steri.Cases, New Shape, Manufactured and distributed by Stryker Leibinger GmbH & Co KG, Distributed in the USA by: Stryker Orthopedics, NON STERILE.
Reason for Recall
Stryker has become aware that the inhomogeneity of the filter paper might potentially compromise the ability of the filter to maintain a sterile barrier during post-sterilization shelf-life.
Distribution Pattern
Worldwide distribution -- US, Canada, France, Germany, Italy, Japan, Norway, Sweden, Switzerland, and the Netherlands.
Lot / Code Information
Part Number: 29-10911 Disposable Paper Filter for Sterilization Container, 30x29cm, new type (P/100); 29-10912 Disposable Paper Filter for Sterilization Container, 60x 29cm, old type (P/100), obsolete (Part not distributed in the US); 29-10913 Dispoable Paper Filter for Sterilization Container, 60x29cm new type (P/100) (Part not distributed in the US); 29-10915 Disposable Paper Filter, 4-holes, for Coiner (Part not distributed in the US)
Other Recalls from Stryker Craniomaxillofacial Division
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1092-2015 | Class II | MEDPOR BARRIER Sheets Rectangle Product Usa... | Dec 17, 2014 |
| Z-1091-2015 | Class II | MEDPOR BARRIER Sheets Orbital Floor Implant ... | Dec 17, 2014 |
| Z-1090-2015 | Class II | MEDPOR Surgical Implant Contoured Two Piece Chi... | Dec 17, 2014 |
| Z-1093-2015 | Class II | MEDPOR TITAN MAX Orbital Floor and Wall (OFW) M... | Dec 17, 2014 |
| Z-2054-2013 | Class II | Stryker Part Numbers 79-43903 (3cc), 79-43905 (... | Jul 30, 2013 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.